Stockreport

Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF Results clearly exceeded expectations, with a substantial revenue beat leading to smaller losses in what looks like a definite win for investors. Revenues were US$28m an [Read more]